RI Workplace Accessibility Grants

The Job Creation Fund provides financial incentives to new and expanding businesses that meet certain job creation and capital investment targets. Companies deemed eligible to participate may receive up to $1 million for creating or retaining high-paying jobs and for constructing or renovating facilities or making other property improvements. In some cases, companies may receive awards of up to $2 million.

The National Library of Medicine (NLM) supports innovative research and development in biomedical informatics and data science. This funding opportunity focuses on biomedical discovery and data-powered health, integrating streams of complex and interconnected research outputs that can be translated into scientific insights, clinical care, public health practices, and personal wellness to ensure the research is scalable, reproducible, and generalizable. The scope of NLM's interest in these research domains is broad, with emphasis on new and innovative methods and approaches to foster data driven discovery in the biomedical and clinical health sciences as well as domain-independent, scalable, and reusable approaches to discovery, curation, analysis, organization, and management of health-related data and digital objects.

The Alamo Small Business Grant Program is available to businesses located in the city of Alamo. It provides 50% reimbursement, up to $2,500, for projects such as storefront improvements, signage, repairs, renovations and equipment purchases. For a business to qualify for the Alamo Small Business Grant, it must have been in operation for a minimum of 24 consecutive months. Also, the business owner must have a yearly lease. In addition to completing an application, owners will need to describe their business, their project and the project budget. Tax returns for the past two years and documented leases from the business's landlord agreeing to the project are also required.

The Maryland Business Ready Sites Program (MBRSP) aims to accelerate investment by growing our inventory of shovel-ready sites across the state. By providing financial support to defray the costs of site characterization and site improvements and providing collaborative marketing support, this program will enable significant investment across Maryland from the leading industries of today and tomorrow. MBRSP was created by Governor Wes Moore on December 19, 2024 by Executive Order, which reimagined how the State of Maryland fosters economic growth. MEDCO is proud to implement this program in close coordination with state, county and municipal economic development officials across Maryland.

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,